{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) is the causal gene for autosomal dominant familial Parkinson's disease. The I2020T mutation in LRRK2 leads to increased susceptibility to post-translational degradation compared to wild-type LRRK2.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism by linking the I2020T mutation in LRRK2 to an increase in protein degradation and subsequent neurodegeneration."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study evaluates the protective effect of I2020T mutant LRRK2 against hydrogen peroxide-induced apoptosis and compares it to wild-type LRRK2. The assays model the disease mechanism by assessing protein stability and function.",
          "judgment": "Yes",
          "reasoning": "The assays used (protein degradation analysis and apoptosis protection) are relevant to the disease mechanism defined in Step 1."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The study uses wild-type LRRK2 as a control and compares it with the I2020T mutant. Proteolysis inhibitors are used to recover protein levels.",
          "judgment": "Yes",
          "reasoning": "Basic controls (wild-type vs. mutant) and experimental replicates (e.g., treatment with proteolysis inhibitors) are included, supporting the validity of the assays."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The I2020T mutation impairs the protective effect of LRRK2 against apoptosis and is associated with increased protein degradation.",
          "judgment": "Yes",
          "reasoning": "The functional data supports a pathogenic role for the I2020T mutation by demonstrating reduced protein stability and impaired neuroprotection."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The functional evidence supports that the I2020T mutation in LRRK2 is pathogenic, as it increases protein degradation and impairs neuroprotection. The strength of this evidence is moderate due to the clear demonstration of functional impairment but lack of extensive controls or statistical details."
    }
  ]
}